Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer

Author:

Bala Vanessa-Meletia1ORCID,Lampropoulou Dimitra Ioanna2ORCID,Grammatikaki Stamatiki3,Kouloulias Vassilios4ORCID,Lagopati Nefeli3ORCID,Aravantinos Gerasimos5,Gazouli Maria3ORCID

Affiliation:

1. Hygeia Hospital, Erithrou Stavrou 4, 15123 Marousi, Greece

2. ECONCARE, Chatzigianni Mexi 5, 11528 Athens, Greece

3. Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

4. Radiation Oncology Unit, 2nd Department of Radiology, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

5. Euroclinic, Athanasiadou 7-9, 11521 Athens, Greece

Abstract

Hyperthermia has the potential to damage cancerous tissue by increasing the body temperature. However, targeting cancer cells whilst protecting the surrounding tissues is often challenging, especially when implemented in clinical practice. In this direction, there are data showing that the combination of nanotechnology and hyperthermia offers more successful penetration of nanoparticles in the tumor environment, thus allowing targeted hyperthermia in the region of interest. At the same time, unlike radiotherapy, the use of non-ionizing radiation makes hyperthermia an attractive therapeutic option. This review summarizes the existing literature regarding the use of hyperthermia and nanoparticles in cancer, with a focus on nanoparticle-induced cytotoxicity mechanisms.

Funder

Hellenic Society of Medical Oncology

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference123 articles.

1. Cancer statistics for the year 2020: An overview;Ferlay;Int. J. Cancer,2021

2. Cancer: An unknown territory; rethinking before going ahead;Upadhyay;Genes Dis.,2021

3. Chemotherapy: A double-edged sword in cancer treatment;Behranvand;Cancer Immunol. Immunother.,2022

4. Les essais qui changent les pratiques: Le point en 2022;Antoni;Cancer/Radiothérapie,2022

5. Nebenwirkungen der Chemotherapie;Hauner;Der Urol.,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3